English

ASTRO MED INC /NEW/

EDGAR

ALOT Quarterly report (10-Q) · filed 2026-06-08

Annual consolidated revenue for 2026: about USD 150.5M, using the latest reported figures. The previous period, 2025, was about USD 151.3M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

39.4 million USD

2027 Q1 · USD

Exact inputs and evidence

Revenue: 39364000 USD Source

Operating margin

3.97%

2027 Q1 · %

Exact inputs and evidence

Operating Income: 1562000 USD Source
Revenue: 39364000 USD Source

Operating cash flow

3.02 million USD

2027 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: 3021000 USD Source

Free cash flow

2.99 million USD

2027 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: 3021000 USD Source
Capital Expenditure: 36000 USD Source

Cash and cash equivalents: 4.68 million USD 2026-04-30 Source
Exact value

4675000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

152 million USD

2025-05-01 – 2026-04-30

Exact inputs and evidence

Revenue: 36102000 USD · 2025-05-01 – 2025-07-31 Source
Revenue: 39169000 USD · 2025-08-01 – 2025-10-31 Source
Revenue: 150515000 USD · 2025-02-01 – 2026-01-31 Source
Revenue: 112979000 USD · 2025-02-01 – 2025-10-31 Source
Revenue: 39364000 USD · 2026-02-01 – 2026-04-30 Source

Net income

-1.35 million USD

2025-05-01 – 2026-04-30

Exact inputs and evidence

Net income: -1243000 USD · 2025-05-01 – 2025-07-31 Source
Net income: 378000 USD · 2025-08-01 – 2025-10-31 Source
Net income: -2376000 USD · 2025-02-01 – 2026-01-31 Source
Net income: -1242000 USD · 2025-02-01 – 2025-10-31 Source
Net income: 653000 USD · 2026-02-01 – 2026-04-30 Source

Operating cash flow

10.4 million USD

2025-05-01 – 2026-04-30

Exact inputs and evidence

Operating cash flow: 4644000 USD · 2025-02-01 – 2025-07-31 Source
Operating cash flow: 4395000 USD · 2025-02-01 – 2025-04-30 Source
Operating cash flow: 8065000 USD · 2025-02-01 – 2025-10-31 Source
Operating cash flow: 4644000 USD · 2025-02-01 – 2025-07-31 Source
Operating cash flow: 11738000 USD · 2025-02-01 – 2026-01-31 Source
Operating cash flow: 8065000 USD · 2025-02-01 – 2025-10-31 Source
Operating cash flow: 3021000 USD · 2026-02-01 – 2026-04-30 Source

Capital expenditure

308 thousand USD

2025-05-01 – 2026-04-30

Exact inputs and evidence

Capital expenditure: 107000 USD · 2025-02-01 – 2025-07-31 Source
Capital expenditure: 60000 USD · 2025-02-01 – 2025-04-30 Source
Capital expenditure: 193000 USD · 2025-02-01 – 2025-10-31 Source
Capital expenditure: 107000 USD · 2025-02-01 – 2025-07-31 Source
Capital expenditure: 332000 USD · 2025-02-01 – 2026-01-31 Source
Capital expenditure: 193000 USD · 2025-02-01 – 2025-10-31 Source
Capital expenditure: 36000 USD · 2026-02-01 – 2026-04-30 Source

Free cash flow

10.1 million USD

2025-05-01 – 2026-04-30

Exact inputs and evidence

Operating cash flow: 4644000 USD · 2025-02-01 – 2025-07-31 Source
Operating cash flow: 4395000 USD · 2025-02-01 – 2025-04-30 Source
Operating cash flow: 8065000 USD · 2025-02-01 – 2025-10-31 Source
Operating cash flow: 4644000 USD · 2025-02-01 – 2025-07-31 Source
Operating cash flow: 11738000 USD · 2025-02-01 – 2026-01-31 Source
Operating cash flow: 8065000 USD · 2025-02-01 – 2025-10-31 Source
Operating cash flow: 3021000 USD · 2026-02-01 – 2026-04-30 Source
Capital expenditure: 107000 USD · 2025-02-01 – 2025-07-31 Source
Capital expenditure: 60000 USD · 2025-02-01 – 2025-04-30 Source
Capital expenditure: 193000 USD · 2025-02-01 – 2025-10-31 Source
Capital expenditure: 107000 USD · 2025-02-01 – 2025-07-31 Source
Capital expenditure: 332000 USD · 2025-02-01 – 2026-01-31 Source
Capital expenditure: 193000 USD · 2025-02-01 – 2025-10-31 Source
Capital expenditure: 36000 USD · 2026-02-01 – 2026-04-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-06-08.

Financial data available through: 2026-01-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2026-01-31
Operating income: 11 of 11 periods available· newest 2026-01-31
Net income: 11 of 11 periods available· newest 2026-01-31
Operating cash flow: 11 of 11 periods available· newest 2026-01-31
Capital expenditure: 11 of 11 periods available· newest 2026-01-31
Total assets: 11 of 11 periods available· newest 2026-01-31
Total liabilities: 11 of 11 periods available· newest 2026-01-31
Current assets: 11 of 11 periods available· newest 2026-01-31
Current liabilities: 11 of 11 periods available· newest 2026-01-31
Cash and cash equivalents: 11 of 11 periods available· newest 2026-01-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-0.5%

Prior period

USD 151.28 million

2024-02-01 – 2025-01-31
Current period

USD 150.52 million

2025-02-01 – 2026-01-31

Exact inputs and evidence

150515000 − 151283000 = -768000 USD

151283000 USD · 2024-02-01 – 2025-01-31
Inspect prior input Prior source
150515000 USD · 2025-02-01 – 2026-01-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ASTRO MED INC /NEW/ · 2026-01-31 ASTRO MED INC /NEW/ (edgar:8146) Year-over-year change in Revenue: -768000 USD Concept: fundies:Revenue Period: 2025-02-01 to 2026-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 150515000 USD (2025-02-01 to 2026-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#4530557 Filing: 000119312526156927 Input fundies:Revenue: 151283000 USD (2024-02-01 to 2025-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#4532341 Filing: 000119312526156927
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 12.11 million

Prior period

−USD 14.49 million

2024-02-01 – 2025-01-31
Current period

−USD 2.38 million

2025-02-01 – 2026-01-31

Exact inputs and evidence

-2376000 − -14489000 = 12113000 USD

-14489000 USD · 2024-02-01 – 2025-01-31
Inspect prior input Prior source
-2376000 USD · 2025-02-01 – 2026-01-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ASTRO MED INC /NEW/ · 2026-01-31 ASTRO MED INC /NEW/ (edgar:8146) Year-over-year change in Net income: 12113000 USD Concept: fundies:NetIncome Period: 2025-02-01 to 2026-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2376000 USD (2025-02-01 to 2026-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526251606/d154617d10ka.htm#270563 Filing: 000119312526251606 Input fundies:NetIncome: -14489000 USD (2024-02-01 to 2025-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526251606/d154617d10ka.htm#275849 Filing: 000119312526251606
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+142.1%

Prior period

USD 4.85 million

2024-02-01 – 2025-01-31
Current period

USD 11.74 million

2025-02-01 – 2026-01-31

Exact inputs and evidence

11738000 − 4848000 = 6890000 USD

4848000 USD · 2024-02-01 – 2025-01-31
Inspect prior input Prior source
11738000 USD · 2025-02-01 – 2026-01-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ASTRO MED INC /NEW/ · 2026-01-31 ASTRO MED INC /NEW/ (edgar:8146) Year-over-year change in Operating cash flow: 6890000 USD Concept: fundies:OperatingCashFlow Period: 2025-02-01 to 2026-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 11738000 USD (2025-02-01 to 2026-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1928542 Filing: 000119312526156927 Input fundies:OperatingCashFlow: 4848000 USD (2024-02-01 to 2025-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1930190 Filing: 000119312526156927
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-71.5%

Prior period

USD 1.17 million

2024-02-01 – 2025-01-31
Current period

USD 332,000

2025-02-01 – 2026-01-31

Exact inputs and evidence

332000 − 1165000 = -833000 USD

1165000 USD · 2024-02-01 – 2025-01-31
Inspect prior input Prior source
332000 USD · 2025-02-01 – 2026-01-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ASTRO MED INC /NEW/ · 2026-01-31 ASTRO MED INC /NEW/ (edgar:8146) Year-over-year change in Capital expenditure: -833000 USD Concept: fundies:CapitalExpenditure Period: 2025-02-01 to 2026-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 332000 USD (2025-02-01 to 2026-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1942556 Filing: 000119312526156927 Input fundies:CapitalExpenditure: 1165000 USD (2024-02-01 to 2025-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1944299 Filing: 000119312526156927
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-02-01 – 2026-01-31

Revenue USD 150.52 million 100% of revenue
Cost of revenue USD 102.88 million 68% of revenue
Operating expenses USD 46.43 million 31% of revenue
Operating income USD 1.21 million 0.8% of revenue
Tax, interest and other Derived USD 3.58 million 2.4% of revenue
Net income −USD 2.38 million −1.6% of revenue

Cash

Operating cash flow USD 11.74 million 7.8% of revenue
Capital expenditure USD 332,000 0.2% of revenue
Free cash flow Derived USD 11.41 million 7.6% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 94%
2018 95%
2019 94%
2020 98%
2021 98%
2022 Net income was higher than operating income, so the split is not drawn.
2023 96%
2024 94%
2025 Operating loss: operating costs were 106% of revenue.
2026 Net loss: net income was −1.6% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2016-02-01 – 2017-01-31	98448000	92167000 Derived	6281000	2053000 Derived	4228000	5715000 Derived	Source 2016-02-01 – 2017-01-31: 98448000 USD Inspect Revenue Open source 2016-02-01 – 2017-01-31: 6281000 USD Inspect Operating Income Open source 2016-02-01 – 2017-01-31: 4228000 USD Inspect Net Income Open source 2016-02-01 – 2017-01-31: 6953000 USD Inspect Operating Cash Flow Open source 2016-02-01 – 2017-01-31: 1238000 USD Inspect Capital Expenditure Open source
2018 2017-02-01 – 2018-01-31	113401000	107989000 Derived	5412000	2126000 Derived	3286000	1520000 Derived	Source 2017-02-01 – 2018-01-31: 113401000 USD Inspect Revenue Open source 2017-02-01 – 2018-01-31: 5412000 USD Inspect Operating Income Open source 2017-02-01 – 2018-01-31: 3286000 USD Inspect Net Income Open source 2017-02-01 – 2018-01-31: 3724000 USD Inspect Operating Cash Flow Open source 2017-02-01 – 2018-01-31: 2204000 USD Inspect Capital Expenditure Open source
2019 2018-02-01 – 2019-01-31	136657000	127937000 Derived	8720000	2990000 Derived	5730000	2360000 Derived	Source 2018-02-01 – 2019-01-31: 136657000 USD Inspect Revenue Open source 2018-02-01 – 2019-01-31: 8720000 USD Inspect Operating Income Open source 2018-02-01 – 2019-01-31: 5730000 USD Inspect Net Income Open source 2018-02-01 – 2019-01-31: 5005000 USD Inspect Operating Cash Flow Open source 2018-02-01 – 2019-01-31: 2645000 USD Inspect Capital Expenditure Open source
2020 2019-02-01 – 2020-01-31	133446000	131013000 Derived	2433000	674000 Derived	1759000	318000 Derived	Source 2019-02-01 – 2020-01-31: 133446000 USD Inspect Revenue Open source 2019-02-01 – 2020-01-31: 2433000 USD Inspect Operating Income Open source 2019-02-01 – 2020-01-31: 1759000 USD Inspect Net Income Open source 2019-02-01 – 2020-01-31: 3224000 USD Inspect Operating Cash Flow Open source 2019-02-01 – 2020-01-31: 2906000 USD Inspect Capital Expenditure Open source
2021 2020-02-01 – 2021-01-31	116033000	113600000 Derived	2433000	1149000 Derived	1284000	12957000 Derived	Source 2020-02-01 – 2021-01-31: 116033000 USD Inspect Revenue Open source 2020-02-01 – 2021-01-31: 2433000 USD Inspect Operating Income Open source 2020-02-01 – 2021-01-31: 1284000 USD Inspect Net Income Open source 2020-02-01 – 2021-01-31: 15544000 USD Inspect Operating Cash Flow Open source 2020-02-01 – 2021-01-31: 2587000 USD Inspect Capital Expenditure Open source
2022 2021-02-01 – 2022-01-31	117480000	113224000 Derived	4256000	-2173000 Derived	6429000	-402000 Derived	Source 2021-02-01 – 2022-01-31: 117480000 USD Inspect Revenue Open source 2021-02-01 – 2022-01-31: 4256000 USD Inspect Operating Income Open source 2021-02-01 – 2022-01-31: 6429000 USD Inspect Net Income Open source 2021-02-01 – 2022-01-31: 1394000 USD Inspect Operating Cash Flow Open source 2021-02-01 – 2022-01-31: 1796000 USD Inspect Capital Expenditure Open source
2023 2022-02-01 – 2023-01-31	142527000	137084000 Derived	5443000	2782000 Derived	2661000	-3165000 Derived	Source 2022-02-01 – 2023-01-31: 142527000 USD Inspect Revenue Open source 2022-02-01 – 2023-01-31: 5443000 USD Inspect Operating Income Open source 2022-02-01 – 2023-01-31: 2661000 USD Inspect Net Income Open source 2022-02-01 – 2023-01-31: -2936000 USD Inspect Operating Cash Flow Open source 2022-02-01 – 2023-01-31: 229000 USD Inspect Capital Expenditure Open source
2024 2023-02-01 – 2024-01-31	148086000	139290000 Derived	8796000	4102000 Derived	4694000	11479000 Derived	Source 2023-02-01 – 2024-01-31: 148086000 USD Inspect Revenue Open source 2023-02-01 – 2024-01-31: 8796000 USD Inspect Operating Income Open source 2023-02-01 – 2024-01-31: 4694000 USD Inspect Net Income Open source 2023-02-01 – 2024-01-31: 12354000 USD Inspect Operating Cash Flow Open source 2023-02-01 – 2024-01-31: 875000 USD Inspect Capital Expenditure Open source
2025 2024-02-01 – 2025-01-31	151283000	159923000 Derived	-8640000	5849000 Derived	-14489000	3683000 Derived	Source 2024-02-01 – 2025-01-31: 151283000 USD Inspect Revenue Open source 2024-02-01 – 2025-01-31: -8640000 USD Inspect Operating Income Open source 2024-02-01 – 2025-01-31: -14489000 USD Inspect Net Income Open source 2024-02-01 – 2025-01-31: 4848000 USD Inspect Operating Cash Flow Open source 2024-02-01 – 2025-01-31: 1165000 USD Inspect Capital Expenditure Open source
2026 2025-02-01 – 2026-01-31	150515000	149309000 Derived	1206000	3582000 Derived	-2376000	11406000 Derived	Source 2025-02-01 – 2026-01-31: 150515000 USD Inspect Revenue Open source 2025-02-01 – 2026-01-31: 1206000 USD Inspect Operating Income Open source 2025-02-01 – 2026-01-31: -2376000 USD Inspect Net Income Open source 2025-02-01 – 2026-01-31: 11738000 USD Inspect Operating Cash Flow Open source 2025-02-01 – 2026-01-31: 332000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 150.5M 2026

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-01-31	Revenue	98448000	Revenue: 98448000 Open source
20182018-01-31	Revenue	113401000	Revenue: 113401000 Open source
20192019-01-31	Revenue	136657000	Revenue: 136657000 Open source
20202020-01-31	Revenue	133446000	Revenue: 133446000 Open source
20212021-01-31	Revenue	116033000	Revenue: 116033000 Open source
20222022-01-31	Revenue	117480000	Revenue: 117480000 Open source
20232023-01-31	Revenue	142527000	Revenue: 142527000 Open source
20242024-01-31	Revenue	148086000	Revenue: 148086000 Open source
20252025-01-31	Revenue	151283000	Revenue: 151283000 Open source
20262026-01-31	Revenue	150515000	Revenue: 150515000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-0.5% 2026

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-01-31	Year over year	4%	Revenue: 98448000 Open source Revenue: 94658000 Open source
20182018-01-31	Year over year	15.2%	Revenue: 113401000 Open source Revenue: 98448000 Open source
20192019-01-31	Year over year	20.5%	Revenue: 136657000 Open source Revenue: 113401000 Open source
20202020-01-31	Year over year	-2.3%	Revenue: 133446000 Open source Revenue: 136657000 Open source
20212021-01-31	Year over year	-13%	Revenue: 116033000 Open source Revenue: 133446000 Open source
20222022-01-31	Year over year	1.2%	Revenue: 117480000 Open source Revenue: 116033000 Open source
20232023-01-31	Year over year	21.3%	Revenue: 142527000 Open source Revenue: 117480000 Open source
20242024-01-31	Year over year	3.9%	Revenue: 148086000 Open source Revenue: 142527000 Open source
20252025-01-31	Year over year	2.2%	Revenue: 151283000 Open source Revenue: 148086000 Open source
20262026-01-31	Year over year	-0.5%	Revenue: 150515000 Open source Revenue: 151283000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 0.8% 2026

Net margin -1.6% 2026

Free cash flow margin 7.6% 2026

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-01-31	Operating margin	6.4%	Operating Income: 6281000 Open source Revenue: 98448000 Open source
20182018-01-31	Operating margin	4.8%	Operating Income: 5412000 Open source Revenue: 113401000 Open source
20192019-01-31	Operating margin	6.4%	Operating Income: 8720000 Open source Revenue: 136657000 Open source
20202020-01-31	Operating margin	1.8%	Operating Income: 2433000 Open source Revenue: 133446000 Open source
20212021-01-31	Operating margin	2.1%	Operating Income: 2433000 Open source Revenue: 116033000 Open source
20222022-01-31	Operating margin	3.6%	Operating Income: 4256000 Open source Revenue: 117480000 Open source
20232023-01-31	Operating margin	3.8%	Operating Income: 5443000 Open source Revenue: 142527000 Open source
20242024-01-31	Operating margin	5.9%	Operating Income: 8796000 Open source Revenue: 148086000 Open source
20252025-01-31	Operating margin	-5.7%	Operating Income: -8640000 Open source Revenue: 151283000 Open source
20262026-01-31	Operating margin	0.8%	Operating Income: 1206000 Open source Revenue: 150515000 Open source
20172017-01-31	Net margin	4.3%	Net Income: 4228000 Open source Revenue: 98448000 Open source
20182018-01-31	Net margin	2.9%	Net Income: 3286000 Open source Revenue: 113401000 Open source
20192019-01-31	Net margin	4.2%	Net Income: 5730000 Open source Revenue: 136657000 Open source
20202020-01-31	Net margin	1.3%	Net Income: 1759000 Open source Revenue: 133446000 Open source
20212021-01-31	Net margin	1.1%	Net Income: 1284000 Open source Revenue: 116033000 Open source
20222022-01-31	Net margin	5.5%	Net Income: 6429000 Open source Revenue: 117480000 Open source
20232023-01-31	Net margin	1.9%	Net Income: 2661000 Open source Revenue: 142527000 Open source
20242024-01-31	Net margin	3.2%	Net Income: 4694000 Open source Revenue: 148086000 Open source
20252025-01-31	Net margin	-9.6%	Net Income: -14489000 Open source Revenue: 151283000 Open source
20262026-01-31	Net margin	-1.6%	Net Income: -2376000 Open source Revenue: 150515000 Open source
20172017-01-31	Free cash flow margin	5.8%	Revenue: 98448000 Open source Operating Cash Flow: 6953000 Open source Capital Expenditure: 1238000 Open source
20182018-01-31	Free cash flow margin	1.3%	Revenue: 113401000 Open source Operating Cash Flow: 3724000 Open source Capital Expenditure: 2204000 Open source
20192019-01-31	Free cash flow margin	1.7%	Revenue: 136657000 Open source Operating Cash Flow: 5005000 Open source Capital Expenditure: 2645000 Open source
20202020-01-31	Free cash flow margin	0.2%	Revenue: 133446000 Open source Operating Cash Flow: 3224000 Open source Capital Expenditure: 2906000 Open source
20212021-01-31	Free cash flow margin	11.2%	Revenue: 116033000 Open source Operating Cash Flow: 15544000 Open source Capital Expenditure: 2587000 Open source
20222022-01-31	Free cash flow margin	-0.3%	Revenue: 117480000 Open source Operating Cash Flow: 1394000 Open source Capital Expenditure: 1796000 Open source
20232023-01-31	Free cash flow margin	-2.2%	Revenue: 142527000 Open source Operating Cash Flow: -2936000 Open source Capital Expenditure: 229000 Open source
20242024-01-31	Free cash flow margin	7.8%	Revenue: 148086000 Open source Operating Cash Flow: 12354000 Open source Capital Expenditure: 875000 Open source
20252025-01-31	Free cash flow margin	2.4%	Revenue: 151283000 Open source Operating Cash Flow: 4848000 Open source Capital Expenditure: 1165000 Open source
20262026-01-31	Free cash flow margin	7.6%	Revenue: 150515000 Open source Operating Cash Flow: 11738000 Open source Capital Expenditure: 332000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 11.7M 2026

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-01-31	Operating cash flow	6953000	Operating Cash Flow: 6953000 Open source
20182018-01-31	Operating cash flow	3724000	Operating Cash Flow: 3724000 Open source
20192019-01-31	Operating cash flow	5005000	Operating Cash Flow: 5005000 Open source
20202020-01-31	Operating cash flow	3224000	Operating Cash Flow: 3224000 Open source
20212021-01-31	Operating cash flow	15544000	Operating Cash Flow: 15544000 Open source
20222022-01-31	Operating cash flow	1394000	Operating Cash Flow: 1394000 Open source
20232023-01-31	Operating cash flow	-2936000	Operating Cash Flow: -2936000 Open source
20242024-01-31	Operating cash flow	12354000	Operating Cash Flow: 12354000 Open source
20252025-01-31	Operating cash flow	4848000	Operating Cash Flow: 4848000 Open source
20262026-01-31	Operating cash flow	11738000	Operating Cash Flow: 11738000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 11.4M 2026

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-01-31	Free cash flow	5715000	Operating Cash Flow: 6953000 Open source Capital Expenditure: 1238000 Open source
20182018-01-31	Free cash flow	1520000	Operating Cash Flow: 3724000 Open source Capital Expenditure: 2204000 Open source
20192019-01-31	Free cash flow	2360000	Operating Cash Flow: 5005000 Open source Capital Expenditure: 2645000 Open source
20202020-01-31	Free cash flow	318000	Operating Cash Flow: 3224000 Open source Capital Expenditure: 2906000 Open source
20212021-01-31	Free cash flow	12957000	Operating Cash Flow: 15544000 Open source Capital Expenditure: 2587000 Open source
20222022-01-31	Free cash flow	-402000	Operating Cash Flow: 1394000 Open source Capital Expenditure: 1796000 Open source
20232023-01-31	Free cash flow	-3165000	Operating Cash Flow: -2936000 Open source Capital Expenditure: 229000 Open source
20242024-01-31	Free cash flow	11479000	Operating Cash Flow: 12354000 Open source Capital Expenditure: 875000 Open source
20252025-01-31	Free cash flow	3683000	Operating Cash Flow: 4848000 Open source Capital Expenditure: 1165000 Open source
20262026-01-31	Free cash flow	11406000	Operating Cash Flow: 11738000 Open source Capital Expenditure: 332000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

44.1% 2026

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-01-31	Liabilities / assets	15.7%	Total Liabilities: 13128000 Open source Total Assets: 83665000 Open source
20182018-01-31	Liabilities / assets	48%	Total Liabilities: 58666000 Open source Total Assets: 122313000 Open source
20192019-01-31	Liabilities / assets	41.4%	Total Liabilities: 49208000 Open source Total Assets: 118983000 Open source
20202020-01-31	Liabilities / assets	38.8%	Total Liabilities: 45289000 Open source Total Assets: 116664000 Open source
20212021-01-31	Liabilities / assets	35.3%	Total Liabilities: 40790000 Open source Total Assets: 115473000 Open source
20222022-01-31	Liabilities / assets	29.5%	Total Liabilities: 33943000 Open source Total Assets: 114955000 Open source
20232023-01-31	Liabilities / assets	39.4%	Total Liabilities: 54840000 Open source Total Assets: 139207000 Open source
20242024-01-31	Liabilities / assets	32.2%	Total Liabilities: 42969000 Open source Total Assets: 133251000 Open source
20252025-01-31	Liabilities / assets	48%	Total Liabilities: 69845000 Open source Total Assets: 145595000 Open source
20262026-01-31	Liabilities / assets	44.1%	Total Liabilities: 60704000 Open source Total Assets: 137566000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.84× 2026

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-01-31	Current assets / current liabilities	5.12×	Current Assets: 61423000 Open source Current Liabilities: 11985000 Open source
20182018-01-31	Current assets / current liabilities	2.43×	Current Assets: 62948000 Open source Current Liabilities: 25912000 Open source
20192019-01-31	Current assets / current liabilities	2.54×	Current Assets: 62608000 Open source Current Liabilities: 24665000 Open source
20202020-01-31	Current assets / current liabilities	2.25×	Current Assets: 60151000 Open source Current Liabilities: 26767000 Open source
20212021-01-31	Current assets / current liabilities	2.9×	Current Assets: 60721000 Open source Current Liabilities: 20968000 Open source
20222022-01-31	Current assets / current liabilities	3.18×	Current Assets: 63778000 Open source Current Liabilities: 20035000 Open source
20232023-01-31	Current assets / current liabilities	2.13×	Current Assets: 79762000 Open source Current Liabilities: 37498000 Open source
20242024-01-31	Current assets / current liabilities	2.58×	Current Assets: 76674000 Open source Current Liabilities: 29761000 Open source
20252025-01-31	Current assets / current liabilities	1.68×	Current Assets: 78017000 Open source Current Liabilities: 46346000 Open source
20262026-01-31	Current assets / current liabilities	1.84×	Current Assets: 70704000 Open source Current Liabilities: 38371000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2016-02-01 – 2017-01-31	USD 4.23 million Exact value Exact value: 4228000 USD 2016-02-01 – 2017-01-31: 4228000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASTRO MED INC /NEW/ · 2017-01-31 ASTRO MED INC /NEW/ (edgar:8146) Net Income: 4228000 USD Concept: fundies:NetIncome Period: 2016-02-01 to 2017-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ANetIncome&period=2017-01-31&surface=latest&period_type=duration&start=2016-02-01&unit=USD&dimensions= Input fundies:NetIncome: 4228000 USD (2016-02-01 to 2017-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312519102788/alot-20190131.xml#1882716 Filing: 000119312519102788 The citation records this snapshot. The page link may show a newer release later.	USD 6.95 million Exact value Exact value: 6953000 USD 2016-02-01 – 2017-01-31: 6953000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASTRO MED INC /NEW/ · 2017-01-31 ASTRO MED INC /NEW/ (edgar:8146) Operating Cash Flow: 6953000 USD Concept: fundies:OperatingCashFlow Period: 2016-02-01 to 2017-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3AOperatingCashFlow&period=2017-01-31&surface=latest&period_type=duration&start=2016-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6953000 USD (2016-02-01 to 2017-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312519102788/alot-20190131.xml#1882449 Filing: 000119312519102788 The citation records this snapshot. The page link may show a newer release later.	USD 1.24 million Exact value Exact value: 1238000 USD 2016-02-01 – 2017-01-31: 1238000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASTRO MED INC /NEW/ · 2017-01-31 ASTRO MED INC /NEW/ (edgar:8146) Capital Expenditure: 1238000 USD Concept: fundies:CapitalExpenditure Period: 2016-02-01 to 2017-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ACapitalExpenditure&period=2017-01-31&surface=latest&period_type=duration&start=2016-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1238000 USD (2016-02-01 to 2017-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312519102788/alot-20190131.xml#1885326 Filing: 000119312519102788 The citation records this snapshot. The page link may show a newer release later.	USD 5.72 million Calculation and evidence 6953000 − 1238000 USD Exact free cash flow: 5715000 USD 2016-02-01 – 2017-01-31: 6953000 USD · Inspect Operating Cash Flow · Source 2016-02-01 – 2017-01-31: 1238000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASTRO MED INC /NEW/ · 2017-01-31 ASTRO MED INC /NEW/ (edgar:8146) Free cash flow: 5715000 USD Concept: free-cash-flow Period: 2016-02-01 to 2017-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6953000 USD (2016-02-01 to 2017-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312519102788/alot-20190131.xml#1882449 Filing: 000119312519102788 Input fundies:CapitalExpenditure: 1238000 USD (2016-02-01 to 2017-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312519102788/alot-20190131.xml#1885326 Filing: 000119312519102788 The citation records this snapshot. The page link may show a newer release later.
2018 2017-02-01 – 2018-01-31	USD 3.29 million Exact value Exact value: 3286000 USD 2017-02-01 – 2018-01-31: 3286000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASTRO MED INC /NEW/ · 2018-01-31 ASTRO MED INC /NEW/ (edgar:8146) Net Income: 3286000 USD Concept: fundies:NetIncome Period: 2017-02-01 to 2018-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ANetIncome&period=2018-01-31&surface=latest&period_type=duration&start=2017-02-01&unit=USD&dimensions= Input fundies:NetIncome: 3286000 USD (2017-02-01 to 2018-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312520103834/alot-20200131.xml#201843 Filing: 000119312520103834 The citation records this snapshot. The page link may show a newer release later.	USD 3.72 million Exact value Exact value: 3724000 USD 2017-02-01 – 2018-01-31: 3724000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASTRO MED INC /NEW/ · 2018-01-31 ASTRO MED INC /NEW/ (edgar:8146) Operating Cash Flow: 3724000 USD Concept: fundies:OperatingCashFlow Period: 2017-02-01 to 2018-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3AOperatingCashFlow&period=2018-01-31&surface=latest&period_type=duration&start=2017-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3724000 USD (2017-02-01 to 2018-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312520103834/alot-20200131.xml#226845 Filing: 000119312520103834 The citation records this snapshot. The page link may show a newer release later.	USD 2.2 million Exact value Exact value: 2204000 USD 2017-02-01 – 2018-01-31: 2204000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASTRO MED INC /NEW/ · 2018-01-31 ASTRO MED INC /NEW/ (edgar:8146) Capital Expenditure: 2204000 USD Concept: fundies:CapitalExpenditure Period: 2017-02-01 to 2018-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ACapitalExpenditure&period=2018-01-31&surface=latest&period_type=duration&start=2017-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2204000 USD (2017-02-01 to 2018-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312520103834/alot-20200131.xml#268214 Filing: 000119312520103834 The citation records this snapshot. The page link may show a newer release later.	USD 1.52 million Calculation and evidence 3724000 − 2204000 USD Exact free cash flow: 1520000 USD 2017-02-01 – 2018-01-31: 3724000 USD · Inspect Operating Cash Flow · Source 2017-02-01 – 2018-01-31: 2204000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASTRO MED INC /NEW/ · 2018-01-31 ASTRO MED INC /NEW/ (edgar:8146) Free cash flow: 1520000 USD Concept: free-cash-flow Period: 2017-02-01 to 2018-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3724000 USD (2017-02-01 to 2018-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312520103834/alot-20200131.xml#226845 Filing: 000119312520103834 Input fundies:CapitalExpenditure: 2204000 USD (2017-02-01 to 2018-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312520103834/alot-20200131.xml#268214 Filing: 000119312520103834 The citation records this snapshot. The page link may show a newer release later.
2019 2018-02-01 – 2019-01-31	USD 5.73 million Exact value Exact value: 5730000 USD 2018-02-01 – 2019-01-31: 5730000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASTRO MED INC /NEW/ · 2019-01-31 ASTRO MED INC /NEW/ (edgar:8146) Net Income: 5730000 USD Concept: fundies:NetIncome Period: 2018-02-01 to 2019-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ANetIncome&period=2019-01-31&surface=latest&period_type=duration&start=2018-02-01&unit=USD&dimensions= Input fundies:NetIncome: 5730000 USD (2018-02-01 to 2019-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312521114283/d56468d10k.htm#2011797 Filing: 000119312521114283 The citation records this snapshot. The page link may show a newer release later.	USD 5.01 million Exact value Exact value: 5005000 USD 2018-02-01 – 2019-01-31: 5005000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASTRO MED INC /NEW/ · 2019-01-31 ASTRO MED INC /NEW/ (edgar:8146) Operating Cash Flow: 5005000 USD Concept: fundies:OperatingCashFlow Period: 2018-02-01 to 2019-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3AOperatingCashFlow&period=2019-01-31&surface=latest&period_type=duration&start=2018-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5005000 USD (2018-02-01 to 2019-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312521114283/d56468d10k.htm#1116726 Filing: 000119312521114283 The citation records this snapshot. The page link may show a newer release later.	USD 2.65 million Exact value Exact value: 2645000 USD 2018-02-01 – 2019-01-31: 2645000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASTRO MED INC /NEW/ · 2019-01-31 ASTRO MED INC /NEW/ (edgar:8146) Capital Expenditure: 2645000 USD Concept: fundies:CapitalExpenditure Period: 2018-02-01 to 2019-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ACapitalExpenditure&period=2019-01-31&surface=latest&period_type=duration&start=2018-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2645000 USD (2018-02-01 to 2019-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312521114283/d56468d10k.htm#2046744 Filing: 000119312521114283 The citation records this snapshot. The page link may show a newer release later.	USD 2.36 million Calculation and evidence 5005000 − 2645000 USD Exact free cash flow: 2360000 USD 2018-02-01 – 2019-01-31: 5005000 USD · Inspect Operating Cash Flow · Source 2018-02-01 – 2019-01-31: 2645000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASTRO MED INC /NEW/ · 2019-01-31 ASTRO MED INC /NEW/ (edgar:8146) Free cash flow: 2360000 USD Concept: free-cash-flow Period: 2018-02-01 to 2019-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5005000 USD (2018-02-01 to 2019-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312521114283/d56468d10k.htm#1116726 Filing: 000119312521114283 Input fundies:CapitalExpenditure: 2645000 USD (2018-02-01 to 2019-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312521114283/d56468d10k.htm#2046744 Filing: 000119312521114283 The citation records this snapshot. The page link may show a newer release later.
2020 2019-02-01 – 2020-01-31	USD 1.76 million Exact value Exact value: 1759000 USD 2019-02-01 – 2020-01-31: 1759000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASTRO MED INC /NEW/ · 2020-01-31 ASTRO MED INC /NEW/ (edgar:8146) Net Income: 1759000 USD Concept: fundies:NetIncome Period: 2019-02-01 to 2020-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ANetIncome&period=2020-01-31&surface=latest&period_type=duration&start=2019-02-01&unit=USD&dimensions= Input fundies:NetIncome: 1759000 USD (2019-02-01 to 2020-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312522108120/d234033d10k.htm#1991231 Filing: 000119312522108120 The citation records this snapshot. The page link may show a newer release later.	USD 3.22 million Exact value Exact value: 3224000 USD 2019-02-01 – 2020-01-31: 3224000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASTRO MED INC /NEW/ · 2020-01-31 ASTRO MED INC /NEW/ (edgar:8146) Operating Cash Flow: 3224000 USD Concept: fundies:OperatingCashFlow Period: 2019-02-01 to 2020-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3AOperatingCashFlow&period=2020-01-31&surface=latest&period_type=duration&start=2019-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3224000 USD (2019-02-01 to 2020-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312522108120/d234033d10k.htm#1090011 Filing: 000119312522108120 The citation records this snapshot. The page link may show a newer release later.	USD 2.91 million Exact value Exact value: 2906000 USD 2019-02-01 – 2020-01-31: 2906000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASTRO MED INC /NEW/ · 2020-01-31 ASTRO MED INC /NEW/ (edgar:8146) Capital Expenditure: 2906000 USD Concept: fundies:CapitalExpenditure Period: 2019-02-01 to 2020-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ACapitalExpenditure&period=2020-01-31&surface=latest&period_type=duration&start=2019-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2906000 USD (2019-02-01 to 2020-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312522108120/d234033d10k.htm#2028289 Filing: 000119312522108120 The citation records this snapshot. The page link may show a newer release later.	USD 318,000 Calculation and evidence 3224000 − 2906000 USD Exact free cash flow: 318000 USD 2019-02-01 – 2020-01-31: 3224000 USD · Inspect Operating Cash Flow · Source 2019-02-01 – 2020-01-31: 2906000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASTRO MED INC /NEW/ · 2020-01-31 ASTRO MED INC /NEW/ (edgar:8146) Free cash flow: 318000 USD Concept: free-cash-flow Period: 2019-02-01 to 2020-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3224000 USD (2019-02-01 to 2020-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312522108120/d234033d10k.htm#1090011 Filing: 000119312522108120 Input fundies:CapitalExpenditure: 2906000 USD (2019-02-01 to 2020-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312522108120/d234033d10k.htm#2028289 Filing: 000119312522108120 The citation records this snapshot. The page link may show a newer release later.
2021 2020-02-01 – 2021-01-31	USD 1.28 million Exact value Exact value: 1284000 USD 2020-02-01 – 2021-01-31: 1284000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASTRO MED INC /NEW/ · 2021-01-31 ASTRO MED INC /NEW/ (edgar:8146) Net Income: 1284000 USD Concept: fundies:NetIncome Period: 2020-02-01 to 2021-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ANetIncome&period=2021-01-31&surface=latest&period_type=duration&start=2020-02-01&unit=USD&dimensions= Input fundies:NetIncome: 1284000 USD (2020-02-01 to 2021-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312523103662/d415415d10k.htm#1972963 Filing: 000119312523103662 The citation records this snapshot. The page link may show a newer release later.	USD 15.54 million Exact value Exact value: 15544000 USD 2020-02-01 – 2021-01-31: 15544000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASTRO MED INC /NEW/ · 2021-01-31 ASTRO MED INC /NEW/ (edgar:8146) Operating Cash Flow: 15544000 USD Concept: fundies:OperatingCashFlow Period: 2020-02-01 to 2021-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3AOperatingCashFlow&period=2021-01-31&surface=latest&period_type=duration&start=2020-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 15544000 USD (2020-02-01 to 2021-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312523103662/d415415d10k.htm#1084633 Filing: 000119312523103662 The citation records this snapshot. The page link may show a newer release later.	USD 2.59 million Exact value Exact value: 2587000 USD 2020-02-01 – 2021-01-31: 2587000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASTRO MED INC /NEW/ · 2021-01-31 ASTRO MED INC /NEW/ (edgar:8146) Capital Expenditure: 2587000 USD Concept: fundies:CapitalExpenditure Period: 2020-02-01 to 2021-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ACapitalExpenditure&period=2021-01-31&surface=latest&period_type=duration&start=2020-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2587000 USD (2020-02-01 to 2021-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312523103662/d415415d10k.htm#2005193 Filing: 000119312523103662 The citation records this snapshot. The page link may show a newer release later.	USD 12.96 million Calculation and evidence 15544000 − 2587000 USD Exact free cash flow: 12957000 USD 2020-02-01 – 2021-01-31: 15544000 USD · Inspect Operating Cash Flow · Source 2020-02-01 – 2021-01-31: 2587000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASTRO MED INC /NEW/ · 2021-01-31 ASTRO MED INC /NEW/ (edgar:8146) Free cash flow: 12957000 USD Concept: free-cash-flow Period: 2020-02-01 to 2021-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 15544000 USD (2020-02-01 to 2021-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312523103662/d415415d10k.htm#1084633 Filing: 000119312523103662 Input fundies:CapitalExpenditure: 2587000 USD (2020-02-01 to 2021-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312523103662/d415415d10k.htm#2005193 Filing: 000119312523103662 The citation records this snapshot. The page link may show a newer release later.
2022 2021-02-01 – 2022-01-31	USD 6.43 million Exact value Exact value: 6429000 USD 2021-02-01 – 2022-01-31: 6429000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASTRO MED INC /NEW/ · 2022-01-31 ASTRO MED INC /NEW/ (edgar:8146) Net Income: 6429000 USD Concept: fundies:NetIncome Period: 2021-02-01 to 2022-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ANetIncome&period=2022-01-31&surface=latest&period_type=duration&start=2021-02-01&unit=USD&dimensions= Input fundies:NetIncome: 6429000 USD (2021-02-01 to 2022-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000095017024043875/alot-20240131.htm#2700828 Filing: 000095017024043875 The citation records this snapshot. The page link may show a newer release later.	USD 1.39 million Exact value Exact value: 1394000 USD 2021-02-01 – 2022-01-31: 1394000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASTRO MED INC /NEW/ · 2022-01-31 ASTRO MED INC /NEW/ (edgar:8146) Operating Cash Flow: 1394000 USD Concept: fundies:OperatingCashFlow Period: 2021-02-01 to 2022-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3AOperatingCashFlow&period=2022-01-31&surface=latest&period_type=duration&start=2021-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1394000 USD (2021-02-01 to 2022-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000095017024043875/alot-20240131.htm#1377973 Filing: 000095017024043875 The citation records this snapshot. The page link may show a newer release later.	USD 1.8 million Exact value Exact value: 1796000 USD 2021-02-01 – 2022-01-31: 1796000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASTRO MED INC /NEW/ · 2022-01-31 ASTRO MED INC /NEW/ (edgar:8146) Capital Expenditure: 1796000 USD Concept: fundies:CapitalExpenditure Period: 2021-02-01 to 2022-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ACapitalExpenditure&period=2022-01-31&surface=latest&period_type=duration&start=2021-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1796000 USD (2021-02-01 to 2022-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000095017024043875/alot-20240131.htm#1389013 Filing: 000095017024043875 The citation records this snapshot. The page link may show a newer release later.	−USD 402,000 Calculation and evidence 1394000 − 1796000 USD Exact free cash flow: -402000 USD 2021-02-01 – 2022-01-31: 1394000 USD · Inspect Operating Cash Flow · Source 2021-02-01 – 2022-01-31: 1796000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASTRO MED INC /NEW/ · 2022-01-31 ASTRO MED INC /NEW/ (edgar:8146) Free cash flow: -402000 USD Concept: free-cash-flow Period: 2021-02-01 to 2022-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1394000 USD (2021-02-01 to 2022-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000095017024043875/alot-20240131.htm#1377973 Filing: 000095017024043875 Input fundies:CapitalExpenditure: 1796000 USD (2021-02-01 to 2022-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000095017024043875/alot-20240131.htm#1389013 Filing: 000095017024043875 The citation records this snapshot. The page link may show a newer release later.
2023 2022-02-01 – 2023-01-31	USD 2.66 million Exact value Exact value: 2661000 USD 2022-02-01 – 2023-01-31: 2661000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASTRO MED INC /NEW/ · 2023-01-31 ASTRO MED INC /NEW/ (edgar:8146) Net Income: 2661000 USD Concept: fundies:NetIncome Period: 2022-02-01 to 2023-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ANetIncome&period=2023-01-31&surface=latest&period_type=duration&start=2022-02-01&unit=USD&dimensions= Input fundies:NetIncome: 2661000 USD (2022-02-01 to 2023-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000095017025054163/alot-20250131.htm#3644189 Filing: 000095017025054163 The citation records this snapshot. The page link may show a newer release later.	−USD 2.94 million Exact value Exact value: -2936000 USD 2022-02-01 – 2023-01-31: -2936000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASTRO MED INC /NEW/ · 2023-01-31 ASTRO MED INC /NEW/ (edgar:8146) Operating Cash Flow: -2936000 USD Concept: fundies:OperatingCashFlow Period: 2022-02-01 to 2023-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3AOperatingCashFlow&period=2023-01-31&surface=latest&period_type=duration&start=2022-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2936000 USD (2022-02-01 to 2023-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000095017025054163/alot-20250131.htm#1732806 Filing: 000095017025054163 The citation records this snapshot. The page link may show a newer release later.	USD 229,000 Exact value Exact value: 229000 USD 2022-02-01 – 2023-01-31: 229000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASTRO MED INC /NEW/ · 2023-01-31 ASTRO MED INC /NEW/ (edgar:8146) Capital Expenditure: 229000 USD Concept: fundies:CapitalExpenditure Period: 2022-02-01 to 2023-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ACapitalExpenditure&period=2023-01-31&surface=latest&period_type=duration&start=2022-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 229000 USD (2022-02-01 to 2023-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000095017025054163/alot-20250131.htm#1747224 Filing: 000095017025054163 The citation records this snapshot. The page link may show a newer release later.	−USD 3.17 million Calculation and evidence -2936000 − 229000 USD Exact free cash flow: -3165000 USD 2022-02-01 – 2023-01-31: -2936000 USD · Inspect Operating Cash Flow · Source 2022-02-01 – 2023-01-31: 229000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASTRO MED INC /NEW/ · 2023-01-31 ASTRO MED INC /NEW/ (edgar:8146) Free cash flow: -3165000 USD Concept: free-cash-flow Period: 2022-02-01 to 2023-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2936000 USD (2022-02-01 to 2023-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000095017025054163/alot-20250131.htm#1732806 Filing: 000095017025054163 Input fundies:CapitalExpenditure: 229000 USD (2022-02-01 to 2023-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000095017025054163/alot-20250131.htm#1747224 Filing: 000095017025054163 The citation records this snapshot. The page link may show a newer release later.
2024 2023-02-01 – 2024-01-31	USD 4.69 million Exact value Exact value: 4694000 USD 2023-02-01 – 2024-01-31: 4694000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASTRO MED INC /NEW/ · 2024-01-31 ASTRO MED INC /NEW/ (edgar:8146) Net Income: 4694000 USD Concept: fundies:NetIncome Period: 2023-02-01 to 2024-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ANetIncome&period=2024-01-31&surface=latest&period_type=duration&start=2023-02-01&unit=USD&dimensions= Input fundies:NetIncome: 4694000 USD (2023-02-01 to 2024-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526251606/d154617d10ka.htm#281154 Filing: 000119312526251606 The citation records this snapshot. The page link may show a newer release later.	USD 12.35 million Exact value Exact value: 12354000 USD 2023-02-01 – 2024-01-31: 12354000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASTRO MED INC /NEW/ · 2024-01-31 ASTRO MED INC /NEW/ (edgar:8146) Operating Cash Flow: 12354000 USD Concept: fundies:OperatingCashFlow Period: 2023-02-01 to 2024-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3AOperatingCashFlow&period=2024-01-31&surface=latest&period_type=duration&start=2023-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 12354000 USD (2023-02-01 to 2024-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1931837 Filing: 000119312526156927 The citation records this snapshot. The page link may show a newer release later.	USD 875,000 Exact value Exact value: 875000 USD 2023-02-01 – 2024-01-31: 875000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASTRO MED INC /NEW/ · 2024-01-31 ASTRO MED INC /NEW/ (edgar:8146) Capital Expenditure: 875000 USD Concept: fundies:CapitalExpenditure Period: 2023-02-01 to 2024-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ACapitalExpenditure&period=2024-01-31&surface=latest&period_type=duration&start=2023-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 875000 USD (2023-02-01 to 2024-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1946044 Filing: 000119312526156927 The citation records this snapshot. The page link may show a newer release later.	USD 11.48 million Calculation and evidence 12354000 − 875000 USD Exact free cash flow: 11479000 USD 2023-02-01 – 2024-01-31: 12354000 USD · Inspect Operating Cash Flow · Source 2023-02-01 – 2024-01-31: 875000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASTRO MED INC /NEW/ · 2024-01-31 ASTRO MED INC /NEW/ (edgar:8146) Free cash flow: 11479000 USD Concept: free-cash-flow Period: 2023-02-01 to 2024-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 12354000 USD (2023-02-01 to 2024-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1931837 Filing: 000119312526156927 Input fundies:CapitalExpenditure: 875000 USD (2023-02-01 to 2024-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1946044 Filing: 000119312526156927 The citation records this snapshot. The page link may show a newer release later.
2025 2024-02-01 – 2025-01-31	−USD 14.49 million Exact value Exact value: -14489000 USD 2024-02-01 – 2025-01-31: -14489000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASTRO MED INC /NEW/ · 2025-01-31 ASTRO MED INC /NEW/ (edgar:8146) Net Income: -14489000 USD Concept: fundies:NetIncome Period: 2024-02-01 to 2025-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ANetIncome&period=2025-01-31&surface=latest&period_type=duration&start=2024-02-01&unit=USD&dimensions= Input fundies:NetIncome: -14489000 USD (2024-02-01 to 2025-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526251606/d154617d10ka.htm#275849 Filing: 000119312526251606 The citation records this snapshot. The page link may show a newer release later.	USD 4.85 million Exact value Exact value: 4848000 USD 2024-02-01 – 2025-01-31: 4848000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASTRO MED INC /NEW/ · 2025-01-31 ASTRO MED INC /NEW/ (edgar:8146) Operating Cash Flow: 4848000 USD Concept: fundies:OperatingCashFlow Period: 2024-02-01 to 2025-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3AOperatingCashFlow&period=2025-01-31&surface=latest&period_type=duration&start=2024-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4848000 USD (2024-02-01 to 2025-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1930190 Filing: 000119312526156927 The citation records this snapshot. The page link may show a newer release later.	USD 1.17 million Exact value Exact value: 1165000 USD 2024-02-01 – 2025-01-31: 1165000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASTRO MED INC /NEW/ · 2025-01-31 ASTRO MED INC /NEW/ (edgar:8146) Capital Expenditure: 1165000 USD Concept: fundies:CapitalExpenditure Period: 2024-02-01 to 2025-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ACapitalExpenditure&period=2025-01-31&surface=latest&period_type=duration&start=2024-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1165000 USD (2024-02-01 to 2025-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1944299 Filing: 000119312526156927 The citation records this snapshot. The page link may show a newer release later.	USD 3.68 million Calculation and evidence 4848000 − 1165000 USD Exact free cash flow: 3683000 USD 2024-02-01 – 2025-01-31: 4848000 USD · Inspect Operating Cash Flow · Source 2024-02-01 – 2025-01-31: 1165000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASTRO MED INC /NEW/ · 2025-01-31 ASTRO MED INC /NEW/ (edgar:8146) Free cash flow: 3683000 USD Concept: free-cash-flow Period: 2024-02-01 to 2025-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4848000 USD (2024-02-01 to 2025-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1930190 Filing: 000119312526156927 Input fundies:CapitalExpenditure: 1165000 USD (2024-02-01 to 2025-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1944299 Filing: 000119312526156927 The citation records this snapshot. The page link may show a newer release later.
2026 2025-02-01 – 2026-01-31	−USD 2.38 million Exact value Exact value: -2376000 USD 2025-02-01 – 2026-01-31: -2376000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ASTRO MED INC /NEW/ · 2026-01-31 ASTRO MED INC /NEW/ (edgar:8146) Net Income: -2376000 USD Concept: fundies:NetIncome Period: 2025-02-01 to 2026-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ANetIncome&period=2026-01-31&surface=latest&period_type=duration&start=2025-02-01&unit=USD&dimensions= Input fundies:NetIncome: -2376000 USD (2025-02-01 to 2026-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526251606/d154617d10ka.htm#270563 Filing: 000119312526251606 The citation records this snapshot. The page link may show a newer release later.	USD 11.74 million Exact value Exact value: 11738000 USD 2025-02-01 – 2026-01-31: 11738000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ASTRO MED INC /NEW/ · 2026-01-31 ASTRO MED INC /NEW/ (edgar:8146) Operating Cash Flow: 11738000 USD Concept: fundies:OperatingCashFlow Period: 2025-02-01 to 2026-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3AOperatingCashFlow&period=2026-01-31&surface=latest&period_type=duration&start=2025-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 11738000 USD (2025-02-01 to 2026-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1928542 Filing: 000119312526156927 The citation records this snapshot. The page link may show a newer release later.	USD 332,000 Exact value Exact value: 332000 USD 2025-02-01 – 2026-01-31: 332000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ASTRO MED INC /NEW/ · 2026-01-31 ASTRO MED INC /NEW/ (edgar:8146) Capital Expenditure: 332000 USD Concept: fundies:CapitalExpenditure Period: 2025-02-01 to 2026-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146/explain?concept=fundies%3ACapitalExpenditure&period=2026-01-31&surface=latest&period_type=duration&start=2025-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 332000 USD (2025-02-01 to 2026-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1942556 Filing: 000119312526156927 The citation records this snapshot. The page link may show a newer release later.	USD 11.41 million Calculation and evidence 11738000 − 332000 USD Exact free cash flow: 11406000 USD 2025-02-01 – 2026-01-31: 11738000 USD · Inspect Operating Cash Flow · Source 2025-02-01 – 2026-01-31: 332000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ASTRO MED INC /NEW/ · 2026-01-31 ASTRO MED INC /NEW/ (edgar:8146) Free cash flow: 11406000 USD Concept: free-cash-flow Period: 2025-02-01 to 2026-01-31 Values: Latest reported Published: 2026-11-02T16:46:22Z Snapshot: a129f8ceab50ad84be3d03c547ad910de0dadbe394dab09d770aeca6b1ceb321 Dimensions: Consolidated View: https://fundies.io/companies/edgar/8146?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 11738000 USD (2025-02-01 to 2026-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1928542 Filing: 000119312526156927 Input fundies:CapitalExpenditure: 332000 USD (2025-02-01 to 2026-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/8146/000119312526156927/alot-20260131.htm#1942556 Filing: 000119312526156927 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

343 filings · 7,885 latest values · 7,885 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000008146, 8146, ALOT, alot, edgar:8146

Also known as ASTRO MED INC /NEW/, AstroNova, Inc.

ASTRO MED INC /NEW/

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2026 2025-02-01 – 2026-01-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation